GridAI Technologies (GRDX) Operating Expenses (2015 - 2026)
GridAI Technologies' (GRDX) quarterly Operating Expenses came in at $13.1 million in Q2 2026, up 1945.86% on a YoY basis from $638864.0 in Q2 2025, and up 224.25% quarter-over-quarter from $4.0 million in Q4 2025.
Analysis
GridAI Technologies (GRDX) Operating Expenses (2015 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Operating Expenses for 12 consecutive years, with $13.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Expenses rose 1945.86% year-over-year to $13.1 million; the trailing twelve-month figure through Jun 2026 stood at $18.7 million (up 309.86% YoY), and the FY2025 full-year result was $6.4 million, down 58.86% from the prior year.
- Operating Expenses improved to $13.1 million in Q2 2026 per GRDX's latest filing, from $4.0 million in the prior quarter.
- Across five years, Operating Expenses topped out at $13.1 million in Q2 2026 and bottomed at -$4.4 million in Q3 2022.
- Historically, Operating Expenses has averaged $3.7 million across 5 years, with a median of $3.4 million in 2023.
- The sharpest annual moves came in 2022 and 2026: Operating Expenses slumped 114.44% in 2022, then surged 1945.86% in 2026.
- Over 5 years, Operating Expenses stood at $2.3 million in 2022, then surged by 79.57% to $4.1 million in 2023, then tumbled by 70.6% to $1.2 million in 2024, then surged by 234.93% to $4.0 million in 2025, then soared by 224.25% to $13.1 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $13.1 million, $4.0 million, and $934787.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 6.54 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 18.20 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 2.09 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 3.00 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -1.05 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 960.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.06 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 2.60 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 367.83 Mn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | 13.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.07 Mn |
| Dec 31, 2025 | 4.03 Mn |
| Sep 30, 2025 | 934,787.00 |
| Jun 30, 2025 | 638,864.00 |
| Mar 31, 2025 | 821,386.00 |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.89 Mn |
| Jun 30, 2024 | 3.43 Mn |
| Mar 31, 2024 | 9.10 Mn |
| Dec 31, 2023 | 4.09 Mn |
| Sep 30, 2023 | 3.43 Mn |
| Jun 30, 2023 | 4.18 Mn |
| Mar 31, 2023 | 4.06 Mn |
| Dec 31, 2022 | 2.28 Mn |
| Sep 30, 2022 | -4.39 Mn |
| Jun 30, 2022 | 5.41 Mn |
| Mar 31, 2022 | 9.38 Mn |
| Dec 31, 2021 | 11.17 Mn |
| Sep 30, 2021 | 30.40 Mn |
| Jun 30, 2021 | 9.28 Mn |